Research ArticleClinical Investigation
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann and Miriam Sraieb
Journal of Nuclear Medicine June 2024, 65 (6) 931-937; DOI: https://doi.org/10.2967/jnumed.123.266619
Alexandros Moraitis
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Walter Jentzen
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Pedro Fragoso Costa
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
David Kersting
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Stephan Himmen
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Marta Coelho
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Marian Meckel
3ITM Isotope Technologies Munich SE, Garching/Munich, Germany; and
Cees J.A. van Echteld
4Helacor Consultancy, Oberwil, Switzerland
Wolfgang P. Fendler
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Ken Herrmann
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
Miriam Sraieb
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 6
June 1, 2024
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann, Miriam Sraieb
Journal of Nuclear Medicine Jun 2024, 65 (6) 931-937; DOI: 10.2967/jnumed.123.266619
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann, Miriam Sraieb
Journal of Nuclear Medicine Jun 2024, 65 (6) 931-937; DOI: 10.2967/jnumed.123.266619
Jump to section
Related Articles
Cited By...
- No citing articles found.